Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov;5(6):485-498.
doi: 10.2217/dmt.15.41.

Adherence in adolescents with Type 1 diabetes: strategies and considerations for assessment in research and practice

Kajal Gandhi  1 , Bach-Mai K Vu  1 , Sahar S Eshtehardi  2 , Rachel M Wasserman  2 , Marisa E Hilliard  2
Affiliations

Adherence in adolescents with Type 1 diabetes: strategies and considerations for assessment in research and practice

Kajal Gandhi et al. Diabetes Manag (Lond). 2015 Nov.

Abstract

Suboptimal adherence remains a significant concern for adolescents with Type 1 diabetes, the treatment regimen for which is complex and includes numerous behaviors. Accurate assessment of adherence is critical for effective healthcare and to measure trial outcomes. Without a valid biomarker of adherence, assessment strategies must rely on measuring management behaviors. This paper provides an overview of approaches to measure adherence, with an emphasis on contemporary, validated measures that are appropriate for current diabetes care. Objective measures include electronic data from diabetes management devices. Subjective measures include self/parent-report questionnaires, structured interviews and diaries/logbooks. Practical strategies for selecting measurement approaches for clinical and research purposes are reviewed, and implications of adherence assessment for clinical care delivery and adherence-promotion are discussed.

Keywords: Type 1 diabetes; adherence; adolescence; assessment; research methods.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Miller KM, Foster NC, RW Beck, et al. Current state of Type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015;38:971–978. - PubMed
    1. Rausch JR, Hood KK, A Delamater, et al. Changes in treatment adherence and glycemic control during the transition to adolescence in Type 1 diabetes. Diabetes Care. 2012;35(6):1219–1224. - PMC - PubMed
    1. Helgeson VS, Honcharuk E, Becker D, Escobar O, Siminerio L. A focus on blood glucose monitoring: relation to glycemic control and determinants of frequency. Pediatr. Diabetes. 2011;12(1):25–30. - PMC - PubMed
    1. Nathan DM. DCCT/EDIC Research Group. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: overview. Diabetes Care. 2014;37(1):9–16. - PMC - PubMed
    1. White NH, Sun W, PA Cleary, et al. Effect of prior intensive therapy in Type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes. 2010;59(5):1244–1253. - PMC - PubMed

LinkOut - more resources